Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia

Koji Sasaki, Hagop Kantarjian, William Wierda, Farhad Ravandi-Kashani, Jeffrey Jorgensen, Sa A. Wang, Joseph Khoury, Naval Daver, Jan Burger, Courtney D. Di Nardo, Nitin Jain, Nicholas J. Short, Zeev Estrov MD, Marina Konopleva MD, PhD, Maro Ohanian DO, Guillermo Garcia-Manero, Tapan Kadia, Yesid Alvarado-Valero, Musa Yilmaz, Sherry PierceRebecca Garris, April Ingram, Jorge Cortes, Susan OʼBrien, Elias Jabbour

Research output: Contribution to journalArticle

Fingerprint Dive into the research topics of 'Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia'. Together they form a unique fingerprint.

Medicine & Life Sciences